cox 189 has been researched along with troglitazone in 4 studies
Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) | Studies (troglitazone) | Trials (troglitazone) | Recent Studies (post-2010) (troglitazone) |
---|---|---|---|---|---|
163 | 49 | 47 | 1,857 | 146 | 287 |
Protein | Taxonomy | cox 189 (IC50) | troglitazone (IC50) |
---|---|---|---|
Bile salt export pump | Rattus norvegicus (Norway rat) | 3.9 | |
Bile salt export pump | Homo sapiens (human) | 5.05 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 0.97 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.208 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.208 | |
Thromboxane-A synthase | Homo sapiens (human) | 2.966 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 2.07 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.238 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 1.03 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.312 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.208 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 1.285 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 1.285 | |
Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 4.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cox 189 and troglitazone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for cox 189 and troglitazone
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |